Cancer survival among people with AIDS (PWA) has been described in developed countries, but there is lack of data from developing countries. The aim of this study was to evaluate survival after cancer diagnosis in PWA and compare it with people without AIDS (non-PWA) in São Paulo, Brazil. A probabilistic record linkage was carried out between the databases of the Population-based Cancer Registry of São Paulo (PBCR-SP) and the AIDS registry of SP (SINAN) to identify PWA who developed cancer. For comparison, non-PWA were frequency matched from the PBCR-SP by cancer site/type, sex, age, and period. Hazard ratio (HR) stratified by matching variables was estimated using a Cox proportional hazards model. A total of 1,294 PWA (20 patients with two primary site tumors) were included in the site/type-specific analyses. AIDS-defining cancers (ADC) comprised 51.9% of cases assessed. The all-cancer 5-year overall survival in PWA was 49.4% versus 72.7% in non-PWA (HR 5 2.64; 95%CI 5 2.39-2.91). Survival was impaired in PWA for both ADC (HR 5 2.93; 95%CI 5 2.49-3.45) and non-ADC (HR 5 2.51; 95%CI 5 2.21-2.84), including bladder (HR 5 8.11; 95% CI 5 2.09-31.52), lung (HR 5 2.93; 95%CI 5 1.97-4.36) and anal cancer (HR 5 2.53; 95%CI 5 1.63-3.94). These disparities were seen mainly in the first year after cancer diagnosis. The overall survival was significantly lower in PWA in comparison with non-PWA in São Paulo, as seen in high-income countries. Efforts to enhance early diagnosis and ensure proper cancer treatment in PWA should be emphasized.
Introduction
The introduction of the highly active antiretroviral therapy (HAART) has greatly improved life expectancy among HIVinfected individuals, turning the infection into a chronic condition and consequently enlarging the HIV-infected population. 1, 2 People with AIDS (PWA) are at increased risk for several types of cancers, both AIDS-defining (ADC), such as Kaposi sarcoma (KS), non-Hodgkin lymphoma (NHL) and cervical cancer (CC) and non-AIDS-defining (NADC) such as lung, anal and Hodgkin lymphoma (HL). [3] [4] [5] [6] Impaired immune response, co-infections with potentially oncogenic viruses, such as the human papilloma virus, hepatitis B and C viruses and higher frequency of exposure to tobacco smoking are some of the known factors associated with an increased risk for cancer. 5 Increasing trends in cancer-related mortality in PWA have been reported in Brazil 7 and other countries. 8 In the city of São Paulo (Brazil), the proportion of cancer-related deaths in PWA has increased from 6.2% in the pre-HAART era (1991) (1992) (1993) (1994) (1995) (1996) to 10.1% in the late post-HAART era (2000) (2001) (2002) (2003) (2004) (2005) (2006) and is likely to reach even higher proportions as this population is living longer and reaching older ages. 8, 9 Nevertheless, survival after cancer diagnosis at a population level has been less explored, especially in low-and middle-income countries.
treatment when HAART became available in 1996 and has developed over the years an internationally recognized AIDS program. 13 In 2013, the country expanded HAART to all HIV-infected people regardless of CD4 count. These unique features make São Paulo a place of interest to study AIDSrelated malignancies in this particular population. 14 The existence of a population-based cancer registry in São Paulo and the mandatory notification of AIDS since the first years of the epidemic enable the conduction of a populationbased study. Its objective was to describe the 5-year overall survival after cancer diagnosis in PWA and compared this to that of selected controls from the general population in São Paulo.
Methods
A probabilistic record linkage was conducted to identify patients with AIDS who were diagnosed with cancer. To summarize briefly this procedure, the database of the "Population-based Cancer Registry of São Paulo" (PBCR-SP) which contains 628,161 cancer cases diagnosed from 1997 to 2012 was linked to the Sistema de Informação de Agravos de Notificação/Information System on Disease Notification database (SINAN) which comprises 87,109 records of people diagnosed with AIDS from 1980 through 2013. Both databases have high coverage and comprehend the same geographical area, namely the city of São Paulo. 15, 16 Therefore, our study is restricted to São Paulo residents only.
In the linkage process, the records were compared based on patient's full name and date of birth using the open source software OpenRecLink (version 2.9). A multi-step procedure was employed and clerical review of matches, based on mother's name and address, was carried out to improve both sensitivity and specificity. After true matches had been identified all personal identifiers were removed from the database to ensure data privacy.
Exclusion criteria were the following: in situ cancers, cancers reported by death certificate only (DCO), cancers diagnosed before AIDS and cancers diagnosed from 2010 onwards leading to incomplete follow up (considering 31st December, 2014 as the end of the observation period), patients aged 75 years and older and patients with two primary non-melanoma skin cancers (NMSC), in that case only the earliest tumor was considered.
Selection of subjects
The record linkage procedure identified 2,571 cancers in PWA. However, 1,257 cases were excluded from the survival analyses as follows: 238 in situ cancers; 281 cancers reported by DCO, 394 cancers diagnosed before AIDS; 323 cancers diagnosed from 2010 onwards; 15 patients aged 75 years and older and six patients with two primary NMSC.
To compare survival probabilities between PWA and people from the general population without AIDS (non-PWA), a control group has been randomly selected following the approach described in a previous study. 11 Our study considered as non-PWA all subjects who could not be matched during the record linkage procedure. A random matching in a 4:1 (non-PWA:PWA) ratio was conducted for all cancer types/sites, with the exception of non-Hodgkin lymphoma (2:1), due to the insufficient cases in the general population. Matching by cancer site, histology (third revision of the International Classification of Diseases for Oncology, ICD-O-3), age Group (10-year age bands), sex and period at cancer diagnosis (1997-2000, 2001-2004 and 2005-2009 ) was prioritized, and when not possible fewer matching variables were used until the matching procedure was possible. In the case of KS, all matching attempts had failed because KS in non-PWA is a rare condition in São Paulo; hence, a 1:1 ratio for controls was used, respecting the same age range (15-74 years) .
Patients with two primary tumors were included only once in the combined analyses (all-cancer, all-ADC and all-NADC). In this case, the first tumor or the one with the poorest prognosis was considered.
Statistical methods
The PBCR-SP conducts routine record linkage with the official mortality database of São Paulo, ensuring updated vital status of cancer patients. For PWA, information on death was also available in the AIDS data set.
Patients included in the analyses were followed up for 5 years, until the outcome of interest (death from any cause) was observed or the end of the observation period was reached (31st December, 2014), whichever occurred earlier. For those patients who survived beyond this threshold, time was right-censored.
Kaplan-Meier survival curves were estimated. To compare the risk for death according to AIDS status (PWA vs. non-PWA), the estimated hazard ratios (HR) and the respective 95% confidence intervals (95%CI) were calculated by means of the Cox proportional hazards model, stratified by What's new? While increasing trends in cancer-related mortality in people with AIDS have been widely reported, survival after cancer diagnosis remains less explored. This is the first population-based study in Brazil and one of the few conducted in developing countries assessing cancer survival in people with AIDS. The large sample size allowed stratification by cancer type/site and analysis of 22 non-AIDS-defining cancers. The results revealed an impaired 5-year overall survival after cancer diagnosis in people with AIDS in comparison to the general population, suggesting that national guidelines for the prevention, early diagnosis and management of cancer among HIV-infected people may be beneficial.
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Tanaka et al. matching variables and adjusted for age (in years). These estimates were provided according to cancer type/site. Cancers were also grouped into AIDS-defining (KS, NHL and CC) and non-AIDS-defining (all other). To describe early and late risk, as presented by other studies, the HRs for 1-and 5-year survival (conditional on surviving the first year) were estimated. 11, 17 In addition, the survival analyses were also stratified by sex and age group (<40 years vs. 40 years), separately to allow for comparison to a previous study. 11 The proportional hazard assumption was graphically assessed based on plots of the log(-log(survival probability)) vs. log (time) and all models met this criterion. This graph shows the hazards over time and when curves are parallel, the assumption of proportionally is not violated.
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The statistical analyses were carried out in Stata (version 13) using anonymized records. This research is part of the "São Paulo AIDS-Cancer Linkage Study" and obtained ethical clearance from all institutions concerned: the School of Public Health (686.849), Municipal Health Secretariat of São Paulo (703.467) and the University of Munich (233-15).
Results
A total of 1,294 PWA were included in the cancer type/sitespecific survival analysis, of which 20 (1.5%) PWA had two primary site tumors. These 20 PWA were considered only once in the all-cancer and respective all-ADC and all-NADC analyses.
The descriptive analysis was based on 1,294 patients ( Table 1 ). The majority of PWA were male (951; 73.5%) and aged 30-49 years at cancer diagnosis (824; 63.7%). Sexual contact was the main mode of exposure to HIV (878; 67.9%). There was a slight predominance of ADC in relation to NADC in the period as a whole, but the ADC:NADC ratio shifted from 2.1:1 (1997-2000) to 0.6:1 (2005-2009), highlighting that NADC are already more frequent than ADC among PWA in São Paulo. Over 40% of ADC were (Table 2 ).
In PWA, the poorest survival was observed for lung cancer (10.5%), followed by liver cancer (11.1%) and leukemia (14.3%). Conversely, the highest survival probabilities were seen for cancers of the thyroid (86.7%), eye (85.7%), vulva and vagina (77.8%) and NMSC (70.6%). The survival curves for ADC and selected NADC can be found in Figures 1 and 2 , respectively.
The results of the 1-and 5-year survival (conditional on surviving the first year) analyses after cancer diagnosis are shown in Table 3 . For lung cancer (HR 5 3.20; 95%CI 5 2.10-4.89), leukemia (HR 5 4.00; 95%CI 5 2.04-7.83) NHL (HR 5 3.73; 95%CI 5 2.90-4.80), among others, the survival gap was restricted to the first year after diagnosis. However, for anal, breast and prostate cancers, risk differences emerged after the first year of diagnosis. For head and neck cancer, NMSC and CC survival disparities could be observed throughout the entire period.
In the stratified analyses by age group and sex no differences were found when comparing groups. Although not statistically significant, the HRs for most cancers assessed tended to be higher in younger (<40 years) than in older patients (40 years) (Table 4 ). 
Discussion
The aim of our study was to compare survival after cancer in PWA and non-PWA. The results revealed that in São Paulo all-cancer 5-year overall survival was significantly lower in PWA than in non-PWA with the same cancer type/site, sex and age (49.4% vs. 72.7%), as reported in previous studies using population-based data. 10, 11 Despite ADC being somewhat more frequent in the period as a whole, NADC had already become more incident in 2005-2009, reflecting the changing AIDS epidemic since the advent of HAART, a well-documented phenomenon in highincome countries. 19 Studies which compared cancer survival before and after HAART revealed that the gap between HIVinfected and their uninfected counterparts narrowed, but still 
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Tanaka et al. remained significant for most cancers, as seen in São Paulo. 10, 11 In the type/site-specific analyses, the probability of survival was impaired in PWA for all ADC and most NADC, in accordance with previous findings using a similar approach. 11 The lowest survival probabilities were found for cancers of the lung, liver and central nervous system (CNS), malignancies with generally poor prognosis. Survival after lung cancer has been described earlier. 10, 11, [20] [21] [22] [23] [24] While some studies reported comparable survival rates between the two populations 10,20,21 our study identified poorer outcomes among PWA. 11, [22] [23] [24] These discrepancies may arise from the diversity of strategies used for the selection of controls and also the HR adjustments. Unlike other studies, 10, 11, 24 in São Paulo, PWA had greater risk of death of anal cancer (HR 5 2.53), but this gap appeared only after the first year of diagnosis. In contrast to non-PWA, survival for leukemia ranked among the least favorable in PWA (14.3%). In a study conducted in Italy, all six patients with leukemia had already died by the end of the first year of follow up, the poorest survival among all cancers assessed and significantly worse in PWA when compared to non-PWA. 11 Our study could not conduct analysis according to leukemia subtype due to insufficient number of cases, but it could be possible that the impaired survival reflected the predominance of acute subtypes, for which prognosis is less favorable.
Wide gaps in survival according to AIDS status were seen for tumors which are not particularly aggressive in the general population, namely bladder cancer (HR 5 8.11), prostate cancer (HR 5 6.07) and NMSC (HR 5 5.39). Prostate cancer does not seem to have more severe presentation in HIV-infected people, 25, 26 but Riedel et al. observed advanced disease more frequently in this population. 27 As for NMSC, our results are in line with a previous study, where this malignancy showed one the greatest survival gaps in Italian patients. 11 Evidences indicate NMSC tends to present in more aggressive forms in HIV-infected people, 28 but elevated HR is likely to be a result of death from other causes, as NMSC is rarely fatal.
The 1-year overall survival analyses revealed that for several cancers, including KS, NHL, lung cancer and leukemia, the survival gap was restricted to the first year after diagnosis, in agreement with a previous report. 11 Findings from the US revealed that HIV-infected patients were more frequently diagnosed with distant disease. 29 The diagnosis of cancer in this population can be challenging. Some signs and symptoms might be initially mistaken by other morbidities that commonly affect the HIV-infected, delaying diagnosis. In an HIV specialty clinic, lung cancer was diagnosed at advanced stage (III and IV) in 88% of HIV-infected patients as opposed to 66% of HIV-uninfected controls. 21 Suneja et al. compared treatment uptake in HIV-infected (88.5% PWA) and HIV-uninfected patients with cancer in the US. HIV-infected patients were less likely to undergo treatment for cancer. The main predictors for the lack of treatment among the HIV-infected included distant and unknown stages, intravenous drug use as exposure to HIV and older age (45-64 years). 29 Another study conducted in the US found discrepancies in the type of treatment for prostate cancer and HL in HIV-infected when compared to HIVuninfected people. 24 The inexistence of national guidelines for the diagnosis and management of malignancies in HIV-infected people in Brazil could also be associated with low survival rates for these patients. 30 A barrier to the establishment of these guidelines is that less information on treatment efficacy is available for NADC in the HIV-infected population because HIV infection is often an exclusion criterion in randomized controlled trials. 31 
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A study assessing death records of PWA in São Paulo revealed that over 90% of all deaths in the post-HAART era were still associated with infectious and parasitic agents, especially tuberculosis (>20%). The same study also identified assault as one of the leading underlying causes of death among PWA in low-income areas of the city. 9 Non-adherence to HIV treatment, including routine medical appointments and use of HAART, could have led to poorer outcomes. Despite the existence of a healthcare system free of cost, patients could face barriers to seek care and follow medical treatment. 32 In São Paulo, HIV disproportionally affects vulnerable populations, including sex workers, drug users, street dwellers and imprisoned people, conditions that could negatively impact adherence to HIV treatment. 33 The strengths of our study are the matching process, which included histological groups among other variables: the number of assessed cancer sites and its representativeness. Matching was an effective tool to ensure comparability of PWA and non-PWA, as it was shown in previous research.
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Due to the number of cancer cases in PWA our study was able to include, in addition to ADCs, 22 NADCs in the type/ site-specific analyses. Survival for some of these cancers has been poorly documented previously. 10, 11, 23 This is the first population-based study estimating survival after cancer among PWA in Brazil and one of the few in developing countries. We employed a multi-step record linkage procedure and clerical review, although time-consuming, to improve the sensitivity and specificity of this method. 6, 34 Our study has also limitations. It was not possible to include clinical staging of the cases in the analyses, because this information was available for a small fraction of cases. Another constraint is that our study was restricted to PWA diagnosed with cancer in the post-HAART era. As the time series of the PBCR-SP begins only in 1997, it was not possible to analyze a longer period and compare survival across periods as previously done in other countries. 10, 11 Because reporting of HIV infection without AIDS was not mandatory until 2013 in Brazil, some of the controls from the general population could be HIV-infected, but since the prevalence of HIV infection in the country is low (0.6% in adults) this would not greatly affect our results. 35 Information on antiretroviral regimen and CD4 count were also not available because they are not routinely collected by the AIDS registry (SINAN).
Since there is no information on smoking status in the databases used in our study, it was not possible to control the analysis for this variable. Smoking is strongly associated with the incidence of cancer as well as early mortality and it is more frequent among HIV-infected people than in the general population. 36 Lastly, the insufficient number of events in some type/sitespecific analyses resulted in large confidence intervals, but since cancer is a rare event, this would not be unexpected.
Our study revealed that there is a significant survival gap between PWA and non-PWA with cancer even after the introduction of HAART. A number of factors could have contributed to unfavorable outcomes in PWA, such as disparities in cancer diagnosis, differences in treatment uptake across populations, lack of specific treatment guidelines for the HIV-infected population and death from other causes including external causes, among others. 21, 29, 37 As in the developed world, an important share of these cancers is related to life style, especially tobacco smoking and is preventable. 6 Although, Brazil has effectively implemented strategies to control tobacco at a population level, 38 it seems to have been less successful in reaching the HIV-infected people. Therefore, approaches targeted at this specific population for preventing cancer, by reducing or eliminating the exposure to key risk factors should be strengthened. The assessment and the implementation of specific screening guidelines for this population as an attempt to ensure early cancer diagnosis should be also considered. As proposed by Goedert et al., physical examination of HIV-infected patients during routine appointments could be a tool to detect some malignancies. 39 In addition to that, efforts to ensure proper cancer treatment in this population should also be emphasized. In this scenario, patients and healthcare providers would greatly benefit from the development of national guidelines for the prevention, early diagnosis and management of cancer among HIV-infected people.
